2014年5月29日
Ms. Shunee Yee to Discuss Language Technology and ‘Big Data’
Beijing, China (May 28, 2014) – CSOFT International, Inc., a leading provider of globalization and communications solutions, announced today that the company’s president and CEO, Ms. Shunee Yee, will speak at the Translators Association of China (TAC) and Globalization and Localization Association’s (GALA) “Language – Key to Global Success” forum tomorrow, May 29th, at the China Beijing International Fair for Trade in Services (CIFTIS).”
Huang Youyi, the Vice President of the Translators Association of China, noted that “through Miss Shunee Yee’s attendance, we will all be enlightened with new perspectives and ideas.”
“Big Data is shifting the position of language technology from aiding faster and cheaper translation to driving faster, more effective global business processes.” says Yee. “New tools and data availability are allowing language-related activities to be parallel with, rather than sequential to other activities in launching a product. On the panel, I will address how realizing this potential requires different working relationships inside companies and with translation agencies.”
Joining Yee on the panel for this one-day program are Kevin Carl of Accenture, Sean Xu of SDL China and Chris Pyne of SAP. The panel will explore how Big Data impacts businesses and workflows for today and tomorrow.
“The panel will share their insights on how companies are building new strategies and business models around Big Data, and how their strategic technology vision must build language into the mix.” adds GALA’s Hans Fenstermacher, the panel moderator. “We will look at what Big Data means to the end-customer experience and how companies are adapting to manage that experience better.”
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com